Old Web
English
Sign In
Acemap
>
authorDetail
>
Karen Melich
Karen Melich
Research Triangle Park
Prostate cancer
Medicine
Urology
Dutasteride
Disease
4
Papers
12
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effect of dutasteride on prostate cancer progression and cancer diagnosis on rebiopsy in the REDEEM active surveillance study.
2011
Journal of Clinical Oncology
Neil Fleshner
M. S. Lucia
Karen Melich
Indrani Nandy
Libby Black
Roger S. Rittmaster
Show All
Source
Cite
Save
Citations (9)
356 INHIBITION OF PROSTATE CANCER PROGRESSION BY DUTASTERIDE AND THE IMPACT ON ANXIETY, QUALITY OF LIFE, AND URINARY SYMPTOMS IN MEN UNDERGOING ACTIVE SURVEILLANCE: REDEEM STUDY RESULTS
2011
The Journal of Urology
Neil Fleshner
M. Scott Lucia
Russell Egerdie
Lorne Aaron
Gregg Eure
Libby Black
Karen Melich
Indrani Nandy
Roger S. Rittmaster
Show All
Source
Cite
Save
Citations (2)
Urothelial Cancer: Markers Natural History & Pathophysiology Podium 9
2011
Neil Fleshner
M. Scott Lucia
Russell Egerdie
Lorne Aaron
Gregg Eure
Libby Black
Karen Melich
Indrani Nandy
Roger S. Rittmaster
Hideki Enokida
Yasutoshi Yamada
Kazumori Kawakami
Hirofumi Yoshino
Satoko Kojima
Kazuya Kawahara
Kenryu Nishiyama
Naohiko Seki
Show All
Source
Cite
Save
Citations (0)
78 EFFECT OF BASELINE CHARACTERISTICS ON RELATIVE RISK OF PROSTATE CANCER PROGRESSION IN THE REDUCTION BY DUTASTERIDE OF CLINICAL PROGRESSION EVENTS IN EXPECTANT MANAGEMENT (REDEEM) TRIAL
2011
European Urology Supplements
Neil Fleshner
M. S. Lucia
B. Egerdie
Libby Black
Karen Melich
Indrani Nandy
Roger S. Rittmaster
Show All
Source
Cite
Save
Citations (1)
1